HomeMedicines › Cosart-H Tablet

Cosart-H Tablet

Losartan (50mg)

MRP (typical)
₹82.28 – ₹111.32
GST rate
5.0%
HSN
3004
Schedule
General
Pack
strip of 10 tablets
Manufacturer
Cipla Ltd

About Cosart-H Tablet

Cosart-H Tablet contains Losartan 50mg, which belongs to the angiotensin receptor blocker (ARB) class of medications. This prescription medicine is available in various strengths and formulations across different pharmaceutical brands in India. As a scheduled medicine, it requires proper medical supervision for dispensing. The product falls under HSN code 3004 and attracts 5% GST as per Indian tax regulations for pharmaceutical products.

Substitutes and alternatives

The following medicines contain the same active ingredient (Losartan (50mg)) and may be offered by pharmacists as substitutes. Actual substitute selection depends on availability at your pharmacy and prescribing doctor's instructions.

Frequently asked

What is the GST rate and HSN code for Cosart-H Tablet?

Cosart-H Tablet falls under HSN code 3004 and attracts 5% GST as per Indian goods and services tax regulations for pharmaceutical medicinal preparations.

What is the schedule classification of Losartan tablets in India?

Losartan-containing tablets like Cosart-H are classified as prescription medicines under general schedule, requiring valid medical prescription for dispensing from licensed pharmacies.

What are common brand variants of Losartan 50mg available in India?

Losartan 50mg tablets in India may include brands like Losar, Repace, Tazar, and Losium among others, manufactured by various pharmaceutical companies with similar composition.

Selling Cosart-H Tablet at your pharmacy?

Nesayo tracks your stock, flags near-expiry, and auto-orders from your distributor when you run low.

Start free →

This page is informational only. Pricing and availability vary by pharmacy, location, and time. Verify current MRP on the printed package before sale. Consult a registered physician or pharmacist for medical advice. Nesayo is not a medical device and does not provide clinical decision support.